Ingredient or product comparison
GHK-Cu for Stress Related Hair Loss Research: Comparison Table
Before selecting a GHK-Cu source for research, understanding formulation stability, bioavailability, and study-validated concentrations is critical. The table below compares key parameters across preparation types. Lyophilized powder (reconstituted) 1–5% w/v <
This source-based comparison does not add ratings or recommend a winner.
- Before selecting a GHK-Cu source for research, understanding formulation stability, bioavailability, and study-validated concentrations is critical. The table below compares key parameters across preparation types.
- Lyophilized powder (reconstituted)
- 1–5% w/v
- <24 hours
- Yes. Clinical trials used reconstituted peptide
- High. Immediate use after mixing preserves copper binding
- Gold standard for research. Maximum control over dosing and stability
- Pre-mixed serum (pH-buffered)
- 0.5–1%
- 30–60 days refrigerated
- Limited. Few commercial formulations match trial specs
- Moderate. Depends on stabilizer quality and pH maintenance
- Acceptable if third-party assay confirms concentration; verify storage conditions
- Liposomal encapsulation
- 0.1–0.5%
- 90+ days
- Emerging. Small-scale studies show penetration enhancement
- High. Lipid carriers improve dermal delivery but reduce aqueous bioavailability
- Promising for topical use; insufficient data for systemic or in vitro research
- Anhydrous oil suspension
- 0.05–0.2%
- 6–12 months
- None. No peer-reviewed trials
- Very low. Copper-peptide complex unstable in non-aqueous environments
- Not recommended. Stability comes at cost of activity loss